摘要
目的:探讨影响宫颈癌患者新辅助化疗(NACT)敏感性的相关因素。方法:回顾分析2011年4月至2015年2月天津市中心妇产科医院收治的106例IB2~IIB期宫颈癌患者资料,行NACT 1~3个疗程,术前评价治疗效果。分析病理类型、临床分期、肿瘤直径、组织学分级、治疗前血清鳞状上皮抗原(SCC-Ag)、血红蛋白、血小板、血小板与淋巴细胞比值(PLR)与NACT敏感性的关系。结果:NACT有效率为64.15%(68/106)。NACT有效组的手术时间、术后淋巴结转移率、宫颈深间质浸润率均低于无效组(P〈0.05)。单因素分析显示,治疗前肿瘤直径、SCC-Ag、PLR与宫颈癌NACT敏感性有关(P〈0.05)。多因素分析显示,治疗前肿瘤直径、SCC-Ag、PLR是影响宫颈癌NACT敏感性的独立危险因素(P〈0.05)。结论:治疗前肿瘤直径、SCC-Ag、PLR对宫颈癌NACT的敏感性有一定的预测价值。
Objective:To explore the effective factors for sensitivity of neoadjuvant chemotherapy(NACT) in cervical cancer. Methods:Stage IB2 to IIB disease was present in 106 patients which were all undertaken 1 - 3 courses of NACT and radical hysterectomy in our hos- pital during Apr. 2011 and Feb. 2015. Efficacy lationship of NACT sensitivky with pathological was evaluated preoperatively. To analyze the re- type, clinical stage, tumor diameter, grade of dif- ferentiation,pretreatment level of serum squamous cell carcinoma antigen (SCC-Ag), hemoglo- bin, platelets, platelet and lymphocyte ratio (PLR). Results:The efficiency was 64.15% (68/ 106). Time of operation and the rate of lymph node metastasis and cervical deep stromal infil- tration in effective group was significantly lower than that in invalid group (P〈0. 05 ). Univariate analysis showed that pretreatment tumor diameter, SCC-Ag, PLR was significantly related to NACT sensitivity ( P〈0.05 ). Multivariate analysis showed those pretreatment tumor diameter, SCC-Ag,PLR were independently correlated with NACT sensitivity in cervical cancer (P 〈 0.05 ). Conclusions: Pretreatment tumor diameter, SCC-Ag and PLR showed potentially predic- tive value of NACT sensitivity in cervical cancer.
出处
《现代妇产科进展》
CSCD
北大核心
2015年第7期498-500,共3页
Progress in Obstetrics and Gynecology
关键词
宫颈癌
新辅助化疗
敏感性
血小板与淋巴细胞比值
Cervical cancer
Neoadjuvant chemotherapy (NACT)
Sensitivity
Platelet and lymphocyte ratio (PLR)